Advertisement

Inpharma Weekly

, Volume 1620, Issue 1, pp 4–4 | Cite as

High-dose vs approved-dose fulvestrant for ER+ breast cancer

Clinical study
  • 3 Downloads

Keywords

Breast Cancer Estrogen Postmenopausal Woman Labelling Index Evaluable Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2008

Personalised recommendations